glp 1 cardiovascular risk GLP-1 Agonists in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Results of cardiovascular outcomes trials

Semaglutide starts working quickly, but noticeable weight loss may take some time depending on your lifestyle choices

Tailoring treatment helps people lose fat while protecting muscle and function

Youll learn how in this empowering 4-session video course, led by Americas Nutrition Leader, Zonya Foco, RDN

If you are traveling with bacteriostatic water for reconstitution at your destination, pack the dry lyophilized powder and the water separately

Studies have shown that niacin therapy can increase fasting glucose by approximately 4-11 mg/dL on average, with some patients experiencing more substantial elevations

The Bottom Line GLP1 therapies are changing the game for T2D, and their influence is continuing to spread across the broader chronic disease landscape